Works by Reichert, Vienna

Results: 2
    1

    Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.

    Published in:
    Oncologist, 2021, v. 26, n. 11, p. e2053, doi. 10.1002/onco.13917
    By:
    • Zalcberg, John R.;
    • Heinrich, Michael C.;
    • George, Suzanne;
    • Bauer, Sebastian;
    • Schöffski, Patrick;
    • Serrano, César;
    • Gelderblom, Hans;
    • Jones, Robin L.;
    • Attia, Steven;
    • D'Amato, Gina;
    • Chi, Ping;
    • Reichardt, Peter;
    • Somaiah, Neeta;
    • Meade, Julie;
    • Reichert, Vienna;
    • Shi, Kelvin;
    • Sherman, Matthew L.;
    • Ruiz‐Soto, Rodrigo;
    • von Mehren, Margaret;
    • Blay, Jean‐Yves
    Publication type:
    Article
    2